CD93 and nasopharyngeal carcinoma: Supporting that is the fact that increasing evidence had shown that CD93 plays an important role in the angiogenesis and vasculature of cancer, including nasopharyngeal carcinoma, glioblastoma, colorectal cancer, and pancreatic ductal adenocarcinoma (4–7).